Health IT / Digital Health
Spaces are Available for Thought Leaders and Scholars in the Following Categories
US Health IT, Interoperability and Digital Health Associations
Benefits of Participating
Help address a $528 billion dollar problem adversely affecting the health and wellbeing of tens of millions of people in the US; help develop transformational practice, payment, technology and measurement models that work for all stakeholders involved in delivering medications, vaccines, digital therapeutics and related therapies to US populations; make new connections; provide value to members.
Who is Included
The following are invited to join as institutional study partners
ONC and Related Entities
Associations supporting US interoperability related to medications
Sequoia, Commonwell, HL7, HRBA, SHIEC, Logica Health, others
National Library of Medicine (RXNorm)
NCPDP
Others
Pharmacy Quality Systems
Associations Supporting Health IT / Digital Innovation
EHR Association
Interoperability
Digital App Association(s)
Digital Therapeutics Association(s)
Digital platform associations
Leading Organizations Providing Health IT, Interoperability, and Digital Health Solutions
Benefits of Participating
Help address a $528 billion dollar problem adversely affecting the health and wellbeing of tens of millions of people in the US; help develop transformational practice, payment, technology and measurement models that work for all stakeholders involved in delivering medications, vaccines, digital therapeutics and related therapies to US populations; make new connections; provide value to members.
Who is Included
The following are invited to join as organizational study partners
Medications Management Solutions / Platforms
Personal Health Data Management Platforms
Health Data Clearinghouses / Data Conversion Services / APIs
Digital Therapeutics / Precision Medicine Providers
A.I. / Machine Learning (related to medications)
Large EHR vendors
Senior Leaders, Designees and Support Staff
Benefits of Participating
Help address a $528 billion dollar problem adversely affecting the health and wellbeing of tens of millions of people in the US; help develop transformational practice, payment, technology and measurement models that work for all stakeholders involved in delivering medications, vaccines, digital therapeutics and related therapies to US populations; make new connections; be recognized for leadership.
Who is Included
Senior leaders able to speak for their organizational units, along with their designees and support staff are invited as participants and/or observers. The goal is to have senior leaders empowered to make strategic decisions for their organizations actively engaged in helping achieve transformational action.
Titles along the following lines are welcome:
Board Member
President/CEO
Chief XYZ Officer (Pharmacy, Medical Nursing, Quality, Strategy, Operations, etc.)
Senior Vice President / Vice President
Director
Senior leaders are welcome to invite designees to join or represent them. Support staff, assistants, and interns are also welcome to join as observers or proxies to assist in decision-making.
Researchers with Relevant Expertise
Who is Included
Established researchers with academic affiliations and relevant expertise may join. Assistance in facilitating "boats" and "sections", co-investigation opportunities, and other opportunities are available. Researchers working in foundations, associations or research divisions of organizations are also welcome.
Learn more here.